Přihlásit se Zaregistrujte se zdarma

Poměr krácení společnosti Interpace Biosciences Inc

Jaká je hodnota metriky Poměr krácení společnosti Interpace Biosciences Inc?

Hodnota metriky Poměr krácení společnosti Interpace Biosciences Inc je 0.19

Jaká je definice metriky Poměr krácení?



Poměr krácení (Short ratio) je poměr akcií prodaných na krátko vydělený průměrným denním objemem.

Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.

The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.

Poměr krácení společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Interpace Biosciences Inc

Čemu se věnuje společnost Interpace Biosciences Inc?

advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.

Firmy s metrikou poměr krácení podobnou společnosti Interpace Biosciences Inc